January 2019 FDA Recall Drug by Akorn Inc (D-0515-2019 - Failed Stability Specification; out of specification (OOS) results for a preservative at 9 month stability study.)
This Class III drug recall was voluntarily initiated by Akorn Inc on January 25, 2019 for the product Drug. The FDA reported the reason for recall as failed stability specification; out of specification (oos) results for a preservative at 9 month stability study.. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0515-2019
Failed Stability Specification; out of specification (OOS) results for a preservative at 9 month stability study.
01-25-2019
02-27-2019
a) 4896 tubes; b) 5064 tubes
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Akorn Inc
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide, including Puerto Rico.
11-03-2020
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Clobetasol Propionate Emollient Cream 0.05%, a) 30 gram (NDC 50383-270-30) and b) 60 gram (NDC 50383-270-60) tubes, Rx only. Manufacturer: Akorn Inc. 369 Bayview Ave., Amityville, NY 117701.
Batch or Lot Expiration Information
Lot# a) 357052, exp 4/19/19 b) 356892, exp 4/16/19 and 356927, exp 4/15/19